Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study

Author： Whitehead Robert   McCoy Sheryl   Macdonald John   Rivkin Saul   Neubauer Marcus   Dakhil Shaker   Lenz Heinz-Josef   Tanaka Michael   Abbruzzese James  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.24, Iss.4, 2006-07, pp. : 335-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: A Southwest oncology group (SWOG 9924) study

By Macdonald John   McCoy Sheryl   Whitehead Robert   Iqbal Syma   Wade James   Giguere Jeffrey   Abbruzzese James  

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 485-487

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial

By Sawa Toshiyuki   Yana Takashi   Takada Minoru   Sugiura Takahiko   Kudoh Shinzoh   Kamei Tadashi   Isobe Takeshi   Yamamoto Hidehiko   Yokota Soichiro   Katakami Nobuyuki   Tohda Yuji   Kawakami Akira   Nakanishi Yoichi   Ariyoshi Yutaka  

Investigational New Drugs, Vol. 24, Iss. 2, 2006-03 ,pp. : 151-158

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: A Southwest Oncology Group Study

By Whitehead Robert   Benedetti Jacqueline   Abbruzzese James   Ardalan Bach   Goodwin J.   Balcerzak Stanley   Samlowski Wolfram   Lenz Heinz-Josef   Macdonald John  

Investigational New Drugs, Vol. 22, Iss. 3, 2004-08 ,pp. : 335-341

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) study

By Takeda Koji   Takifuji Nobuhide   Negoro Shunichi   Furuse Kiyoyuki   Nakamura Shinichiro   Takada Yoshiki   Hoso Takanobu   Hayasaka Shinichi   Nakano Takashi   Araki Jun   Senba Hiroshi   Iwami Fumiyuki   Yamaji Yasufumi   Fukuoka Masahiro   Ikegami Harumichi  

Investigational New Drugs, Vol. 25, Iss. 4, 2007-08 ,pp. : 377-383

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282

By Jhawer Minaxi   Mani Sridhar   Lefkopoulou Myrto   Hahn Richard   Harris Jules   Catalano Paul   Haller Daniel  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 447-454

Springer Publishing Company

Access to resources Recommend Favorite